Anavex appoints John Harrison to SAB
This article was originally published in Scrip
Clinical-stage biopharmaceutical company Anavex has appointed Dr John Harrison to its scientific advisory board. Dr Harrison has successfully integrated cognitive testing into drug development programs for many pharmaceutical and biotechnology companies. He is currently honorary senior lecturer in the Department of Medicine at Imperial College in London.